Home › Leukemie › Californië › Los Angeles
Leukemie klinische studies in Los Angeles, CA
16 studies voor Leukemie zoeken deelnemers op locaties in en rond Los Angeles (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruterenFase 3
- Quetzal Site 7, Los Angeles
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RekruterenFase 2
- USC Norris Comprehensive Cancer Center, Los Angeles
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruterenFase 2
- UCLA Medical Center, Los Angeles
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Children s Hospital of Los Angeles, Los Angeles
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruterenFase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruterenFase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Health - Bowyer Oncology Center, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekruterenFase 2
- Children's Hospital Los Angeles, Los Angeles
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RekruterenFase 1/2
- Research Site, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruterenFase 1/2
- Valkyrie Clinical Trials, Los Angeles
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
RekruterenFase 1/2
- David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruterenFase 2
- UCLA Department of Medicine, Los Angeles
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruterenFase 2/3
- Keck School of Medicine of USC, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekruterenFase 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruterenFase 1
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UCLA - Bowyer Oncology Center, Los Angeles
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
RekruterenFase 1
- University of California Los Angeles, Los Angeles
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
RekruterenGezonde vrijwilligers welkom
- Children's Hospital Los Angeles, Los Angeles
Leukemie studies in andere steden
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Chicago, IL16 studies
- Durham, NC13 studies
- Columbus, OH12 studies
- Baldwin Park, CA12 studies
- Nashville, TN12 studies
- Philadelphia, PA12 studies
- Milwaukee, WI11 studies
- Atlanta, GA11 studies
- Seattle, WA11 studies
Andere studies in Los Angeles
- Niet-kleincellige longkanker87 studies
- Kanker (alle vormen)73 studies
- Borstkanker72 studies
- Prostaatkanker61 studies
- Colorectale kanker59 studies
- Metastatische kanker57 studies
- Eierstokkanker50 studies
- Longkanker45 studies
- Plaveiselcelcarcinoom van hoofd en hals42 studies
- Aldermeesklierkanker35 studies
- Endometriumkanker34 studies
- Melanoom34 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.